August 06, 2025 03:03 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Former Jammu and Kashmir Governor Satya Pal Malik dies at 79 | 'Unwarranted on the democratic rights of political parties': INDIA bloc backs Rahul Gandhi after SC slams his 'Chinese intrusion' remark | 'Unjustified and unreasonable': India counters Trump's tariff threat over Russian oil import | Former Jharkhand CM Shibu Soren dies at 81 | ‘Not officially issued’: EC seeks Tejashwi Yadav’s explanation over EPIC card used to allege voter roll omission | Buy and sell products made in India: Modi's 'Swadeshi' pitch amid tariff conflict with US | 'Good step': Donald Trump claims India won't buy oil from Russia; New Delhi sources deny | 'Big headload fell from one of the passengers': Aswini Vaishaw on Delhi station tragedy that killed 18 | ED issues lookout notice against Anil Ambani in Rs 3,000-crore loan fraud case | Former JDS MP Prajwal Revanna convicted in rape case

Lupin launches generic Aricept tablets in the US

| | Mar 31, 2016, at 09:23 pm
#Lupin launches generic Aricept tablets in the US
Mumbai/ Baltimore, Mar 31 (IBNS) Mumbai-based Lupin Limited (Lupin), a transnational pharmaceutical company producing and developing a wide range of branded and generic formulations, biotechnology products and APIs globally, announced on Thursday that its US subsidiary, Lupin Pharmaceuticals Inc. has launched its Donepezil Hydrochloride Tablets, 23 mg having received approval from the United States Food and Drug Administration (FDA) earlier to market a generic equivalent of Eisai Inc's Aricept® Tablets, 23mg.
Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. works in the area of generic medicines and branded formulations.
 
Lupin's Donepezil Hydrochloride Tablets, 23 mg are the AB rated generic equivalent of Eisai Inc's Aricept® Tablets, 23mg. It is indicated for the treatment of dementia of the Alzheimer's type.
 
Aricept® had US sales of USD 47.1 million (IMS MAT December 2015).

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Related Images
Nirmala Sitharaman presents Budget 2025
Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:41 pm
Veedol signs former Indian skipper Sourav Ganguly as brand ambassador
Veedol signs former Indian skipper Sourav Ganguly as brand ambassador Jun 29, 2024, at 06:38 am
In Images: Glimpses from Bengali film Fatafati's premiere
In Images: Glimpses from Bengali film Fatafati's premiere May 13, 2023, at 08:39 pm
Related Videos
RBI announces repo rate cut Jun 06, 2025, at 10:51 am
FM Nirmala Sitharaman presents Budget 2025 Feb 01, 2025, at 03:45 pm
Nirmala Sitharaman on Budget 2024 Jul 23, 2024, at 09:30 pm
Close menu